Skip to main content
. 2021 Mar 23;13(6):1481. doi: 10.3390/cancers13061481

Figure 2.

Figure 2

Generation of immune cell products for application in cancer therapy. Overview of exemplary cell sources and procedures for the generation of representative immune cell products. Additionally, time points of discovery and initial application in clinical trials are indicated. Alternative cell sources are possible for specific immune cell products. INF-γ = Interferon-γ; PBMC = peripheral blood mononuclear cells.